CHARLES RIVER LABORATORIES (CRL)

US1598641074 - Common Stock

269.37  +3.93 (+1.48%)

After market: 269.37 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
3.54B
21.08%
3.976B
12.31%
4.129B
3.86%
4.263B
3.24%
EBITDA
YoY % growth
898.526M
30.43%
963.585M
7.24%
973.446M
1.02%
1.101B
13.10%
N/AN/AN/AN/A
EBIT
YoY % growth
632.986M
39.42%
659.715M
4.22%
659.322M
-0.06%
865.42M
31.26%
N/AN/A
Operating Margin
17.88%16.59%15.97%20.30%N/AN/A
EPS
YoY % growth
10.33
26.90%
11.13
7.74%
10.65
-4.31%
11.11
4.28%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
2.09
-24.78%
Revenue
Q2Q % growth
1.001B
-2.76%
EBITDA
Q2Q % growth
234.19M
EBIT
Q2Q % growth
178.82M
5.84%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
2.46
-17.45%
2.430.031.38%
Q3 2023
Q2Q % growth
2.72
3.42%
2.390.3313.71%
Q2 2023
Q2Q % growth
2.69
-2.89%
2.660.030.95%
Q1 2023
Q2Q % growth
2.78
1.09%
2.610.176.34%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
1.013B
-7.85%
1.001B12.476M1.25%
Q3 2023
Q2Q % growth
1.027B
3.79%
1.011B15.623M1.55%
Q2 2023
Q2Q % growth
1.06B
8.92%
1.064B-4.063M-0.38%
Q1 2023
Q2Q % growth
1.029B
12.63%
996.21M33.163M3.33%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-4.61% -17.26% 1.73% 1.38%
Revenue-0.99% -2.72% -0.3% -0.42%